Hodgkin Lymphoma - Relapsed/Refractory

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
42:23

19th Annual International Ultmann Chicago Lymphoma Symposium

COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccination, and Prophylactic Strategies

FEATURING Natasha Pettit
  • 162 views
  • July 11, 2022
20:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

FEATURING Lindsay Morton
  • 66 views
  • July 8, 2022
  • 1
41:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis, and Treatment

FEATURING Kenneth Cohen
  • 154 views
  • July 8, 2022
03:24

ecancer

NK-Cells Complexed With a Bispecific Antibody May Provide New Treatment Option for Patients With Recurrent/Refractory CD30+ (non-)Hodgkin Lymphomas

FEATURING Yago Nieto
  • 16 views
  • June 23, 2022
03:32

ASCO 2022 Conference Coverage

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of Leukemia and Lymphoma: Results From the WHI-LILAC Study

FEATURING Melissa Loh
  • 20 views
  • June 10, 2022
45:19

Nebraska Oncology Society

CD30 CAR T-Cells in Hodgkin Lymphoma

FEATURING Natalie Grover
  • 210 views
  • June 2, 2022
18:18

Rush University Medical Center

Hodgkin Lymphoma: Managing Brentuximab Vedotin/CPI Dual Refractory Patients

FEATURING Vaishalee Kenkre
  • 22 views
  • May 27, 2022
17:09

Penn Medicine Abramson Cancer Center

Therapeutic Advances in Hodgkin Lymphoma

FEATURING Jakub Svoboda
  • 123 views
  • May 6, 2022
09:18

Penn Medicine Abramson Cancer Center

Penn Medicine Lymphoma Panel Discussion: Toxicity Profile with IO, Salvage Regimen for cHL, Maintenance Rituximab, BTKi for MCL, and 3L Therapy for FL

FEATURING Stephen Schuster, James Gerson, Stefan Barta, Sunita D. Nasta, Elise Chong
  • 27 views
  • May 4, 2022
05:05

ASH 2021 Conference Coverage on VuMedi

A Multi-Institution Analysis of Relapsed Lymphoma Occurring During Pregnancy Including Pharmacokinetics With Antenatal CPI Therapy

FEATURING Faheem Farooq
  • 17 views
  • April 13, 2022
07:23

ASH 2021 Conference Coverage on VuMedi

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monotherapy in R/R cHL

FEATURING Alex Herrera
  • 286 views
  • March 24, 2022
  • 1
14:22

Yale Cancer Center

ASH 2021 Highlights in T-Cell Lymphoma and Hodgkin Lymphoma

FEATURING Tarsheen Sethi
  • 41 views
  • March 24, 2022
09:05

i3 Health

Improving Outcomes in R/R Hodgkin Lymphoma

FEATURING Louis Diehl
  • 29 views
  • March 24, 2022
08:50

UNC Lineberger Comprehensive Cancer Center

Latest Advances in the Management of R/R cHL: The Era of Novel Therapies

FEATURING Natalie Grover
  • 163 views
  • March 23, 2022
  • 1
41:23

University of Colorado Division of Hematology

UC Denver ASH Review: Updates on Lymphomas

FEATURING Steven Bair
  • 84 views
  • March 16, 2022
16:08

John Kuruvilla

KEYNOTE-204 in R/R cHL: How Does This Trial Influence Our Practice?

  • 99 views
  • March 11, 2022
17:03

Stephen M. Ansell

PD-1 Blockade in Hodgkin Lymphoma: Moving Up the Ranks

  • 216 views
  • March 5, 2022
14:45

SOHO 3rd Italian Conference

SOHO Italy 2021: How I Manage Hodgkin Lymphoma in the USA

FEATURING Amanda Cashen
  • 23 views
  • December 23, 2021
06:32

ASH 2021 Conference Coverage on VuMedi

ASH 2021 Updates on CD30-Directed CAR T-Cells for Pediatric Patients With Hodgkin/Non-Hodgkin Lymphoma

FEATURING George Hucks
  • 45 views
  • December 15, 2021
16:42

Scripps Health

Strategies to Minimize Radiation Induced Heart Disease

FEATURING Prabhakar Tripuraneni
  • 165 views
  • November 15, 2021
  • 1
19:21

2021 Virtual ESMO Review

ESMO 2021 Hematologic Malignancies Panel Discussion

FEATURING Julie M. Vose, Harry P. Erba
  • 230 views
  • November 8, 2021
  • 2
15:35

2021 Virtual ESMO Review

ESMO 2021 Highlights on Lymphomas: R/R Marginal Zone Lymphoma, PMLBCL & CHL, Gene Signature in Follicular Lymphoma

FEATURING Julie M. Vose
  • 226 views
  • November 8, 2021
  • 2
14:45

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Progress in Hodgkin Lymphoma: From Biology to Therapy

FEATURING Stephen M. Ansell
  • 18 views
  • October 1, 2021
16:04

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL

FEATURING Ann LaCasce
  • 74 views
  • October 1, 2021
18:54

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Treatment Strategies in Nodular Lymphocyte Predominant HL

FEATURING Ranjana Advani
  • 26 views
  • October 1, 2021

Hodgkin Lymphoma - Relapsed/Refractory

No subtopics